Raffield Laura M, Louie Tin, Sofer Tamar, Jain Deepti, Ipp Eli, Taylor Kent D, Papanicolaou George J, Avilés-Santa Larissa, Lange Leslie A, Laurie Cathy C, Conomos Matthew P, Thornton Timothy A, Chen Yii-Der Ida, Qi Qibin, Cotler Scott, Thyagarajan Bharat, Schneiderman Neil, Rotter Jerome I, Reiner Alex P, Lin Henry J
Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA.
Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.
Hum Mol Genet. 2017 May 15;26(10):1966-1978. doi: 10.1093/hmg/ddx082.
Genetic variants contribute to normal variation of iron-related traits and may also cause clinical syndromes of iron deficiency or excess. Iron overload and deficiency can adversely affect human health. For example, elevated iron storage is associated with increased diabetes risk, although mechanisms are still being investigated. We conducted the first genome-wide association study of serum iron, total iron binding capacity (TIBC), transferrin saturation, and ferritin in a Hispanic/Latino cohort, the Hispanic Community Health Study/Study of Latinos (>12 000 participants) and also assessed the generalization of previously known loci to this population. We then evaluated whether iron-associated variants were associated with diabetes and glycemic traits. We found evidence for a novel association between TIBC and a variant near the gene for protein phosphatase 1, regulatory subunit 3B (PPP1R3B; rs4841132, β = -0.116, P = 7.44 × 10-8). The effect strengthened when iron deficient individuals were excluded (β = -0.121, P = 4.78 × 10-9). Ten of sixteen variants previously associated with iron traits generalized to HCHS/SOL, including variants at the transferrin (TF), hemochromatosis (HFE), fatty acid desaturase 2 (FADS2)/myelin regulatory factor (MYRF), transmembrane protease, serine 6 (TMPRSS6), transferrin receptor (TFR2), N-acetyltransferase 2 (arylamine N-acetyltransferase) (NAT2), ABO blood group (ABO), and GRB2 associated binding protein 3 (GAB3) loci. In examining iron variant associations with glucose homeostasis, an iron-raising variant of TMPRSS6 was associated with lower HbA1c levels (P = 8.66 × 10-10). This association was attenuated upon adjustment for iron measures. In contrast, the iron-raising allele of PPP1R3B was associated with higher levels of fasting glucose (P = 7.70 × 10-7) and fasting insulin (P = 4.79 × 10-6), but these associations were not attenuated upon adjustment for TIBC-so iron is not likely a mediator. These results provide new genetic information on iron traits and their connection with glucose homeostasis.
基因变异导致铁相关性状的正常变异,也可能引发缺铁或铁过载的临床综合征。铁过载和铁缺乏都会对人类健康产生不利影响。例如,铁储存量升高与糖尿病风险增加相关,尽管其机制仍在研究中。我们在西班牙裔/拉丁裔队列(西班牙裔社区健康研究/拉丁裔研究,超过12000名参与者)中开展了第一项关于血清铁、总铁结合力(TIBC)、转铁蛋白饱和度和铁蛋白的全基因组关联研究,并评估了先前已知基因座在该人群中的普遍性。然后,我们评估了与铁相关的变异是否与糖尿病及血糖性状相关。我们发现TIBC与蛋白磷酸酶1调节亚基3B(PPP1R3B;rs4841132,β = -0.116,P = 7.44×10⁻⁸)基因附近的一个变异之间存在新的关联。排除缺铁个体后,这种效应增强(β = -0.121,P = 4.78×10⁻⁹)。先前与铁性状相关的16个变异中有10个在HCHS/SOL中具有普遍性,包括转铁蛋白(TF)、血色素沉着症(HFE)、脂肪酸去饱和酶2(FADS2)/髓磷脂调节因子(MYRF)、跨膜蛋白酶丝氨酸6(TMPRSS6)、转铁蛋白受体(TFR2)、N - 乙酰转移酶2(芳胺N - 乙酰转移酶)(NAT2)、ABO血型(ABO)和GRB2相关结合蛋白3(GAB3)基因座的变异。在研究铁变异与葡萄糖稳态的关联时,TMPRSS6的一个使铁升高的变异与较低的糖化血红蛋白水平相关(P = 8.66×10⁻¹⁰)。调整铁指标后,这种关联减弱。相反,PPP1R3B的使铁升高的等位基因与较高的空腹血糖水平(P = 7.70×10⁻⁷)和空腹胰岛素水平(P = 4.79×10⁻⁶)相关,但调整TIBC后这些关联并未减弱——所以铁不太可能是中介因素。这些结果提供了关于铁性状及其与葡萄糖稳态联系的新的遗传信息。